Chronic eosinophilic leukemia (CEL) was distinguished from hypereosinophilic syndrome (HES) in the 2001 World Health Organization (WHO) criteria. Subsequently, the FIP1L1-PDGFRα (F/P) fusion tyrosine kinase was identified in patients with HES and found to be the most common clonal defect in CEL and the second most frequent mutation in systemic mastocytosis (SM). Introduction of F/P into bone marrow hematopoietic stem cells and progenitors has been used to establish murine models of F/P-myeloproliferative neoplasm and F/P-CEL. IL-5 overexpression and introduction of F/P is required to develop murine CEL. This F/P-CEL model is thought to be an accurate model of the clinical disease. Here we describe the method of F/P-CEL/SM model development and assessment. © Springer Science+Business Media New York 2014.
CITATION STYLE
Yamada, Y., Cancelas, J. A., & Rothenberg, M. E. (2014). Murine models of eosinophilic leukemia: A model of FIP1L1-PDGFRα initiated chronic eosinophilic leukemia/systemic mastocytosis. Methods in Molecular Biology, 1178, 309–320. https://doi.org/10.1007/978-1-4939-1016-8_26
Mendeley helps you to discover research relevant for your work.